These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3324225)

  • 1. [Determination of beta-2-microglobulin levels in patients with systemic lupus erythematosus: correlation with clinical and biological parameters].
    Valencia ME; Molano J; Vázquez JJ; Lavilla P; Khamashta MA; Pintado V; Barbado FJ; Gil Aguado A
    Rev Clin Esp; 1987 Oct; 181(6):310-3. PubMed ID: 3324225
    [No Abstract]   [Full Text] [Related]  

  • 2. beta 2-Microglobulin and systemic lupus erythematosus.
    Yeung CK; Wong KL; Wong WS; Chan KH
    J Rheumatol; 1986 Dec; 13(6):1053-8. PubMed ID: 3550072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the levels of soluble HLA antigens and their light chains (beta 2 microglobulin) in rheumatoid arthritis and systemic lupus erythematosus].
    Konenkov VI; Prokof'ev VF; Glazycheva IIu; Kozhevnikov VS; Nuamov IuN
    Ter Arkh; 1986; 58(7):57-9. PubMed ID: 3532402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta 2 microglobulin and systemic lupus erythematosus].
    Font J; Coca Cardellach A; Ingelmo M
    Rev Clin Esp; 1988 Apr; 182(6):342. PubMed ID: 3043579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
    Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

  • 8. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-beta-2-microglobulin antibodies in systemic lupus erythematosus].
    Kochen Jde A; Nobre MR; de Oliveira RM; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):63-71. PubMed ID: 9435398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum concentration of beta-2-microglobulin, immunologic parameters and kidney function in lupus erythematosus].
    Kolarz G; Scherak D; Fritzsche H; Weissel M
    Verh Dtsch Ges Rheumatol; 1978; 5():118-20. PubMed ID: 81571
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.
    Yamada M; Yagita H; Inoue H; Takanashi T; Matsuda H; Munechika E; Kanamaru Y; Shirato I; Tomino Y; Matushima K; Okumura K; Hashimoto H
    Arthritis Rheum; 2002 Mar; 46(3):735-40. PubMed ID: 11920409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
    Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
    Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus.
    Revillard JP; Vincent C; Rivera S
    J Immunol; 1979 Feb; 122(2):614-8. PubMed ID: 84029
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.